BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19097174)

  • 1. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
    Ayala RM; Martínez-López J; Albízua E; Diez A; Gilsanz F
    Am J Hematol; 2009 Feb; 84(2):79-86. PubMed ID: 19097174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of thrombopoietin and its receptor C-mpl in acute leukemia].
    Guo Y; Bian S; Luo M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):120-3. PubMed ID: 11601235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
    Larson RA; Le Beau MM
    Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
    Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
    Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
    Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
    Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
    Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
    Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI
    Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet production and related pathophysiology in acute myelogenous leukemia at first diagnosis: prognostic implications.
    Trafalis DT; Poulakidas E; Kapsimali V; Tsigris C; Papanicolaou X; Harhalakis N; Nikiforakis E; Mentzikof-Mitsouli C
    Oncol Rep; 2008 Apr; 19(4):1021-6. PubMed ID: 18357391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
    Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
    Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy.
    Wetzler M; Baer MR; Bernstein SH; Blumenson L; Stewart C; Barcos M; Mrózek K; Block AW; Herzig GP; Bloomfield CD
    J Clin Oncol; 1997 Jun; 15(6):2262-8. PubMed ID: 9196139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
    J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The expression pattern of transcription factors (GATA, SCL) and biological characteristics in various leukemia cells].
    Shimamoto T; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1995 Jun; 36(6):547-51. PubMed ID: 7643449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA-1, GATA-2, and stem cell leukemia gene expression in acute myeloid leukemia.
    Shimamoto T; Ohyashiki JH; Ohyashiki K; Kawakubo K; Kimura N; Nakazawa S; Toyama K
    Leukemia; 1994 Jul; 8(7):1176-80. PubMed ID: 8035609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication and biological roles of RhoH in acute myeloid leukaemia.
    Iwasaki T; Katsumi A; Kiyoi H; Tanizaki R; Ishikawa Y; Ozeki K; Kobayashi M; Abe A; Matsushita T; Watanabe T; Amano M; Kojima T; Kaibuchi K; Naoe T
    Eur J Haematol; 2008 Dec; 81(6):454-60. PubMed ID: 18691253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunophenotypic study of acute myeloid leukemia (AML): biological significance and prognostic implications].
    Rigolin GM; Latorraca A; Moretti S; Previati R; Lanza F
    Boll Soc Ital Biol Sper; 1993 May; 69(5):301-5. PubMed ID: 8129911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia.
    Min YJ; Lee JH; Choi SJ; Chi HS; Lee JS; Kim WK; Lee KH
    Leuk Res; 2004 Apr; 28(4):359-65. PubMed ID: 15109535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities.
    Patmasiriwat P; Fraizer GC; Claxton D; Kantarjian H; Saunders GF
    Leukemia; 1996 Jul; 10(7):1127-33. PubMed ID: 8683991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.